financetom
Business
financetom
/
Business
/
Why Longevity Health Stock Is Skyrocketing Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Longevity Health Stock Is Skyrocketing Today
Jul 15, 2025 1:25 PM

Shares of Longevity Health Holdings Inc ( XAGE ) surged on Tuesday afternoon following the announcement of its definitive merger agreement with plasma collection leader True Health Inc.

What To Know: The all-stock transaction will see the combined entity continue trading on Nasdaq under the XAGE ticker. This strategic pivot follows Longevity Health’s mutual termination of a previously announced merger with 20/20 BioLabs. The new deal with True Health, which operates as THPlasma, aims to leverage plasma synergies to drive bioaesthetic innovation.

This merger builds on Longevity’s recent acquisitions of Carmell Therapeutics and Elevai Skincare, which have technologies that utilize plasma-derived growth factors and exosomes. THPlasma plays a role in addressing the U.S. shortfall of plasma-derived therapeutics.

CEO George Chi called the merger a “transformative step expected to supercharge our growth by unlocking access to public markets.”

XAGE Price Action: According to data from Benzinga Pro, Longevity Health ( XAGE ) shares closed Tuesday up 115.50% to $5.70. The stock has a 52-week high of $59.10 and a 52-week low of $2.20.

Read Also: Best Healthcare Stocks Right Now

How To Buy XAGE Stock

By now, you're likely curious about how to participate in the market for Longevity Health Holdings ( XAGE ) — be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

In the case of Longevity Health Holdings ( XAGE ), which is trading at $5.50 this afternoon, $100 would buy you 18.18 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading; either way, it allows you to profit from the share price decline.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Levi Strauss Q1 Adjusted EPS, Net Revenue Increase
Levi Strauss Q1 Adjusted EPS, Net Revenue Increase
Apr 7, 2025
04:41 PM EDT, 04/07/2025 (MT Newswires) -- Levi Strauss (LEVI) reported Q1 adjusted earnings Monday of $0.38 per diluted share, up from $0.25 a year earlier. Analysts polled by FactSet expected $0.28. Net revenue for the quarter ended March 2 was $1.53 billion, up from $1.48 billion a year earlier. Analysts surveyed by FactSet expected $1.54 billion. The firm said...
Broadcom Approves $10 Billion Share Repurchase Program
Broadcom Approves $10 Billion Share Repurchase Program
Apr 7, 2025
04:40 PM EDT, 04/07/2025 (MT Newswires) -- Broadcom ( AVGO ) said Monday its board authorized a share repurchase program to buy back up to $10 billion of common shares. The repurchase program will run through Dec. 31, according to the company. Shares of Broadcom ( AVGO ) were up 2.5% in after-hours activity. ...
Greenbrier Fiscal Q2 Earnings Rise, Revenue Falls; Fiscal 2025 Outlook Adjusted -- Shares Fall After Hours
Greenbrier Fiscal Q2 Earnings Rise, Revenue Falls; Fiscal 2025 Outlook Adjusted -- Shares Fall After Hours
Apr 7, 2025
04:43 PM EDT, 04/07/2025 (MT Newswires) -- Greenbrier (GBX) reported Monday fiscal Q2 earnings of $1.56 per diluted share, up from $1.03 a year earlier. Two analysts polled by FactSet expected $1.78. Revenue for the quarter ended Feb. 28 was $762.1 million, down from $862.7 million a year earlier. Two analysts surveyed by FactSet expected 898.5 million. The company adjusted...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved